Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL) | Leukemia

The 17 fired members of ACIP, including me, have written an article in JAMA about our experience and our concerns. https://t.co/K9T3nDkNUX

@Dr_AmerZeidan Sorry to learn, thanks for sharing. Let’s see what the subgroup analyses reveal: bridged to alloSCT vs. Not, ASXL1mut vs. Not etc.

The Journal of Hematology Oncology Pharmacy (@JHOPjournal) is recruiting HOPA members to serve as manuscript reviewers. This opportunity is ideal for young professionals who are looking to gain expertise in scholarly manuscripts. Apply today: https://t.co/e9VggexftN

Excited to pop over to Austin to talk shop about Heme Malignancies and ASCO updates. Hit me up if you're in town!

👉👉 Happy to share results of investigator initiated trial of Ruxolitinib in Ph-Like ALL. We did not see any significant responses in R/R adult Ph-like B-ALL with ruxolitinib. 👉Looking back at my emails @mkonople and I had initial discussions with Incyte for this trial at ASH

This year's #ASCO25 has been mind blowing in almost all disciplines, with multiple high-quality simultaneous publications, including in hematology! Congrats @ASCO and all presenters! Here are the most impressive malignant hematology studies🧵

👉👉👉Our group’s new article led by Dr @HannahGoulart & Dr @TapKadia Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia AML https://t.co/5vpjucgoiB | @JournalCancer @MDAndersonNews #leusm #endcancer | @sanamloghavi

Multicenter retrospective evaluation of treatment for high risk acute promyelocytic #leukemia: Comparison of the APML4 and ATRA+ATO+GO in high risk #APL conducted by the @HERO_consortium Free access: https://t.co/Yhk0lqtBNK #LeuSM @Berninini #HemOnc

BIG WIN! 🏆 A recent bibliometric analysis published in @CPTLJournal recognizes @UK_COP as a global leader in pharmacy education research. The study ranks UKCOP as the #2 most productive institution worldwide, with 61 publications and 1,127 citations—a testament to the College’s

Your Voice Matters. Your Vote Matters. Board Elections are now open through December 2 - find out more about the candidates, and how to cast your ballot, at the HOPA Election Center: https://t.co/L7mq8KSJmB

👉👉👉Congratulations 🎉 to our own Leukemia PharmD * Dr Adam DiPippo * PharmD for winning 🏅 Clinical Pharmacist of The Year 2024 Award @MDAndersonNews !!! #PharmD #endcancer #leusm @DrHKantarjian @GBorthakur @Marxk @TapKadia @doctorpemm @AlisonGulbis

Can someone tell me who thought it was a good idea to zoom in on every gymnast's feet these Olympic games? Can you also tell me WHY? #Paris2024

Excited to see this in print! An #oncopharm collaboration between 4 centers 👏 With so many new #celltherapy & #genetherapy approvals, centers have to remain agile & develop sustainable methods but it must be done thoughtfully and w/the multidisciplinary care team. @TheIACH

Great work!!!! I can't wait to review the posters online!

Back by popular demand - the only thing better than #HOPA2024 is #HOPA2024 with puppies! Come and say hello, and maybe have a cuddle with them, at 5PM in the Exhibit Hall at Booth 721

FHOPA recognitions at #HOPA2024 featured a rockstar lineup of #pharmacytarheels. Congratulations to @Benyam_Muluneh @lindseyamerine and @lwbpharmd on a well deserved recognition!!!!

Congrats @Benyam_Muluneh on #FHOPA! #Hopa2024

Wow the FDA has been on a roll

Today, I am excited to share the first major deliverable from our White House Initiative on Women’s Health Research: $100 million in funding for women's health research and development as part of ARPA-H's first-ever Sprint for Women’s Health. Together, we will build a new